Nulliparity and late menopause are associated with decreased cognitive decline

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 15, Issue 2, 2003, Pages 161-167

  McLay, Robert N ^a   Maki, Pauline M ^b   Lyketsos, Constantine G ^c  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; AGING; ARTICLE; BIRTH CONTROL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; ESTROGEN THERAPY; FEMALE; HUMAN; LIFESPAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSE; MINI MENTAL STATE EXAMINATION; NULLIPARA; ORAL CONTRACEPTION; POSTMENOPAUSE; PRIORITY JOURNAL; SELF REPORT;

EID: 0037368254     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.15.2.161     Document Type: Article

References (45)

1. Trichopoulos D, MacMahon B, Cole P: Menopause and breast cancer risk. J Natl Cancer Inst 1972; 48:605-613
2. Ramon JM, Escriba JM, Casas I, et al: Age at first full-term pregnancy, lactation, and parity and risk of breast cancer: a case-control study in Spain. Eur J Epidemiol 1996; 12:449-453
3. Isaia GC, Di Stefano M, Ardissone P, et al: Senile osteoporosis: pathophysiology and therapeutic perspectives. Aging (Milan) 1997; 9:77-78
4. Luine V, Park D, Joh T, et al: Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Res 1980; 191:273-277
5. Gould E, Woolley CS, Frankfurt M, et al: Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J of Neurosci 1990; 10:1286-1291
6. Toran-Allerand CD, Miranda RC, Bentham WDL, et al: Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proceedings of the National Academy of Sciences 1992; 89:4668-4672
7. Gangar KF, Vyas S, Whitehead M, et al: Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338:839-842
8. Mooradian AD: Antioxidant properties of steroids. J Steroid Biochem Mol Biol 1993; 45:509-511
9. Srivastava RA, Bhasin N, Srivastava N: Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochem Mol Biol Int 1996; 38:91-101
10. Tang M, Jacobs D, Stern Y, et al: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348:429-432
11. Kawas C, Resnick S, Morrison A, et al: A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997; 48:1517-1521
12. Henderson VW, Paganini-Hill A, Emanuel CK, et al: Estrogen replacement therapy in older women. Arch Neurol 1994; 51:896-900
13. Baldereschi M, Di-Carlo A, Lepore V, et al: Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 1998; 50:996-1002
14. Brenner DE, Kukull WA, Stergachis A, et al: Postmenopausal estrogen therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 1994; 140:262-267
15. Broe GA, Henderson AS, Creasey H, et al: A case-control study of Alzheimer's disease in Australia. Neurology 1990; 40:1698-1707
16. Henderson VW, Paganini-Hill A, Miller BL, et al: Estrogen for Alzheimer's disease in women. Neurology 2000; 54:295-301
17. Mulnard RA, Cotman CW, Kawas C, et al: Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. JAMA 2000; 283:1007-1015
18. Wang PN, Liao SQ, Liu RS, et al: Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 2000; 54:2061-2066
19. Asthana S, Baker LD, Craft S: High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 2001; 57:605-612
20. Resnick SM, Metter EJ, Zonderman AB: Estrogen replacement therapy and longitudinal decline in visual memory: a possible protective effect? Neurology 1997; 49:1491-1497
21. Jacobs DM, Tang MX, Stern Y, et al: Cognitive function in non-demented older women who took estrogen after menopause. Neurology 1998; 50:368-373
22. Barrett-Connor E, Kritz-Silverstein D: Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637-2641
23. Maki P, Zonderman A, Resnick S: Enhanced verbal memory in non-demented elderly women receiving hormone-replacement therapy. Am J Psych 2001; 158:227-233
24. Sherwin BB: Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988; 13:345-357
25. Sherwin BB: Can estrogen keep you smart? Evidence from clinical studies. J Psych Neurosci 1999; 24:315-321
26. Paganini-Hill A, Henderson VW: Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994; 140:256-261
27. Waring SC, Rocca WA, Petersen RC, et al: Postmenopausal estrogen replacement therapy and risk of AD. Neurology 1999; 52:965-970
28. Nappi RE, Sinforiani E, Mauri M, et al: Memory functioning at menopause: impact of age in ovariectomized women. Gynecol Obstet Invest 1999; 47:29-36
29. Smith CA, McCleary CA, Murdock GA, et al: Lifelong estrogen exposure and cognitive performance in elderly women. Brain Cogn 1999; 39:203-218
30. Eaton W, Kessler L: Epidemiologic Field Methods in Psychiatry: The NIMH Epidemiologic Catchment Area Program. Orlando, FL, Academic Press, 1985
31. Lyketsos CG, Chen LS, Anthony JC: Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area study. Am J Psychiatry 1999; 156:58-65
32. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
33. Tombaugh TN, McIntyre NJ: The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992; 40:922-935
34. Richards M, Kuh D, Hardy R, et al: Lifetime cognitive function and timing of the natural menopause. Neurology 1999; 53:308-314
35. Zubialde JP, Lawler F, Clemenson N: Estimated gains in life expectancy with use of postmenopausal estrogen therapy: a decision analysis. J of Fam Pract 1993; 36:271-280
36. McEwen BS, Alves SE: Estrogen actions in the central nervous system. Endocr Rev 1999; 20:279-307
37. al-Azzawi F: Endocrinological aspects of the menopause. Br Med Bull 1992; 48:262-275
38. Amso NN, Crow J, Shaw RW: Comparative immunohistochemical study of oestrogen and progesterone receptors in the fallopian tube and uterus at different stages of the menstrual cycle and the menopause. Hum Reprod 1994; 9:1027-1037
39. Phillips SM, Sherwin BB: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17:485-495
40. Petrakis NL, Wrensch MR, Ernster VL, et al: Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 1987; 40:587-591
41. Bernard A, Duffek L, Torok I, et al: Progesterone and oestradiol levels and cytoplasmic receptor concentrations in the human myometrium at term, before labour and during labour. Acta Physiol Hung 1988; 71:507-510
42. Noci I, Borri P, Periti E, et al: Decidual progesterone and estrogen receptors in the first trimester of pregnancy. Ann N Y Acad Sci 1994; 734:26-32
43. Bernstein L, Pike MC, Ross RK, et al: Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985; 74:741-745
44. Dorgan JF, Reichman ME, Judd JT, et al: Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 1995; 4:381-386
45. Trichopoulos D, Brown J, MacMahon B: Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer 1987; 40:721-725